SIREN : 518906839
EPILLUX is a French company founded 16 years ago, specialized in the sector Soins de beauté. Based in MONTREUIL (93100), this company of category PME shows in 2018 a revenue of 384 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|
| Revenue | 383 545 € | 358 403 € | 302 952 € | 274 134 € | 274 147 € |
| Net income | 36 086 € | 43 023 € | 31 607 € | 121 966 € | 17 855 € |
| EBITDA | 84 590 € | 96 305 € | 67 455 € | 15 792 € | 58 487 € |
| Net margin | 9.4% | 12.0% | 10.4% | 44.5% | 6.5% |
In 2018, EPILLUX achieves revenue of 384 k€. Over the period 2014-2018, the company shows strong growth with a CAGR (compound annual growth rate) of +8.8%. Vs 2017: +7%. After deducting consumption (35 k€), gross margin stands at 348 k€, i.e. a rate of 91%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 85 k€, representing 22.1% of revenue. Warning negative scissor effect: despite revenue change (+7%), EBITDA varies by -12%, reducing margin by 4.8 pts. This reflects costs rising faster than revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 36 k€, i.e. 9.4% of revenue. This profit can be retained or distributed to shareholders.
383 545 €
348 423 €
84 590 €
44 839 €
36 086 €
22.0%
The debt ratio (= Financial debt / Equity x 100) stands at 26%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 60%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 1.1 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 15.7% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
26.231%
60.307%
15.695%
1.107
47.1%
In 2018, the debt ratio of EPILLUX (26.23) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2018, the financial autonomy of EPILLUX (60.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2018, the repayment capacity of EPILLUX (1.11) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 320.30. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 2.3x. Financial charges are adequately covered by operations.
320.302
2.259
In 2018, the liquidity ratio of EPILLUX (320.30) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2018, the interest coverage of EPILLUX (2.3x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 2 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 114 days. Excellent situation: suppliers finance 112 days of the operating cycle (retail model). Inventory turnover is 9 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. WCR is negative (-21 days): operations structurally generate cash. Notable WCR improvement over the period (-345%), freeing up cash.
-22 265 €
2 j
114 j
9 j
-21 j
Based on 207 transactions of similar company sales in 2018, the value of EPILLUX is estimated at 374 791 € (range 177 032€ - 667 988€). With an EBITDA of 84 590€, the sector multiple of 6.3x is applied. The price/revenue ratio is 0.48x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 207 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare EPILLUX with other companies in the same sector:
The revenue of EPILLUX in 2018 is 384 k€.
Yes, EPILLUX generated a net profit of 36 k€ in 2018.
The headquarters of EPILLUX is located in MONTREUIL (93100), in the department Seine-Saint-Denis.
The tax return of EPILLUX is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
EPILLUX operates in the sector Soins de beauté (NAF code 96.02B). See the 'Sector positioning' section above to compare the company with its competitors.